Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a routine maintenance update to the study page. No content changes to the study details or eligibility criteria are indicated by this revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:11:31.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study's recruitment status now indicates it is no longer looking for participants, signaling halted enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision note (v3.6.0) with a formatting change to the Intervention/Treatment header was introduced.
    Difference
    0.6%
    Check dated 2026-06-12T16:28:27.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.5.4 to v3.5.5. This indicates a minor page update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-05T13:13:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer build of the page. This update appears to be a maintenance change and does not alter study details or visible content.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:51.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a backend or interface release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:25.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:51.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.